{
    "2019-09-05": [
        [
            {
                "time": "",
                "original_text": "渝股看台｜智飞生物获两项发明专利证书，莱美药业两高层拟减持股份 拟减持股份",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "发明专利",
                        "莱美药业",
                        "减持"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)实控人蒋仁生解除质押1370万股",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "蒋仁生",
                        "解除质押"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)子公司取得两项发明专利证书",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "子公司",
                        "发明专利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康希诺(6185.HK)：港股疫苗第一股",
                "features": {
                    "keywords": [
                        "康希诺",
                        "港股",
                        "疫苗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}